Jaswinder Singh

机构：Shree Guru Gobind Singh Tricentenary University, IILM University Gurugram, Chitkara University

发表论文 44 篇 · 总被引 215 次 · h-index 7

代表论文

• Early prognostication of COVID-19 to guide hospitalisation versus outpatient monitoring using a point-of-test risk prediction score (2021 · Thorax · 被引 36)
• Treatment Rationale and Study Design for a Randomized, Double-Blind, Placebo-Controlled Phase II Study Evaluating Onartuzumab (MetMAb) in Combination With Bevacizumab Plus mFOLFOX-6 in Patients With Previously Untreated Metastatic Colorectal Cancer (2013 · Clinical Colorectal Cancer · 被引 34)
• Efficacy and safety of abemaciclib alone and with PI3K / mTOR inhibitor LY3023414 or galunisertib versus chemotherapy in previously treated metastatic pancreatic adenocarcinoma: A randomized controlled trial (2023 · Cancer Medicine · 被引 20)
• Regorafenib Prior to Selective Internal Radiation Therapy Using 90Y-Resin Microspheres for Refractory Metastatic Colorectal Cancer Liver Metastases: Analysis of Safety, Dosimetry, and Molecular Markers (2019 · Frontiers in Oncology · 被引 10)
• Elevated oxytocin and noradrenaline indicate higher stress levels in allergic rhinitis patients: Implications for the skin prick diagnosis in a pilot study (2018 · PLoS ONE · 被引 10)
• Early prognostication of COVID-19 to guide hospitalisation versus outpatient monitoring using a point-of-test risk prediction score (2020 · medRxiv · 被引 4)